ConductScience.org, home

Paper41301427

Regulation of Klotho Production by Mineralocorticoid Receptor Signaling in Renal Cell Lines.

Kohm E and 2 others. Biomolecules, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Regulation of Klotho Production by Mineralocorticoid Receptor Signaling in Renal Cell Lines. Papers, record 41301427. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301427

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Regulation of Klotho Production by Mineralocorticoid Receptor Signaling in Renal Cell Lines.
PubMed
Journal
Biomolecules
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-03-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kohm EElena
2Feger MMartina
3Föller MMichael

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, MineralocorticoidMajor topic
GlucuronidaseMajor topic
Signal TransductionMajor topic
KidneyMajor topic
Klotho Proteins
Animals
Dogs
Humans
Rats
Mineralocorticoid Receptor Antagonists
Cell Line
Madin Darby Canine Kidney Cells
Aldosterone
Spironolactone
Gene Expression Regulation
Eplerenone

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
695/2-2.Deutsche ForschungsgemeinschaftPubMed

Source PubMed

Download CSV of grants

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130469400Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease.J Clin Med2018https://conductscience.org/library/papers/30469400PubMed
231199502Regulation of fibroblast growth factor 23 (FGF23) in health and disease.FEBS Lett2019https://conductscience.org/library/papers/31199502PubMed
33485096The synthesis of aldosterone by the adrenal cortex. Two zones (fasciculata and glomerulosa) possess one enzyme for 11 beta-, 18-hydroxylation, and aldehyde synthesis.J Biol Chem1986https://conductscience.org/library/papers/3485096PubMed
439349629Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial.Nat Med2024https://conductscience.org/library/papers/39349629PubMed
519617444The mineralocorticoid receptor and its coregulators.J Mol Endocrinol2009https://conductscience.org/library/papers/19617444PubMed
634461222Nonsteroidal mineralocorticoid receptor antagonism for cardiovascular and renal disorders - New perspectives for combination therapy.Pharmacol Res2021https://conductscience.org/library/papers/34461222PubMed
72357784Use of spironolactone in treatment of hirsutism.Cleve Clin J Med1990https://conductscience.org/library/papers/2357784PubMed
89360552Colocalization of 11 beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia.J Clin Endocrinol Metab1997https://conductscience.org/library/papers/9360552PubMed
939225278Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.N Engl J Med2024https://conductscience.org/library/papers/39225278PubMed
1025376771On the pleotropic actions of mineralocorticoids.Nephron Physiol2014https://conductscience.org/library/papers/25376771PubMed
11166833Antiandrogenic effect of spirolactones: mechanism of action.Endocrinology1975https://conductscience.org/library/papers/166833PubMed
1238947237The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials.Front Med (Lausanne)2024https://conductscience.org/library/papers/38947237PubMed
1334514191Mineralocorticoid Receptor Antagonism in Chronic Kidney Disease.Kidney Int Rep2021https://conductscience.org/library/papers/34514191PubMed
1422012806Regulation of epithelial Na+ channels by adrenal steroids: mineralocorticoid and glucocorticoid effects.Am J Physiol Renal Physiol2012https://conductscience.org/library/papers/22012806PubMed
158421998Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension.Am J Cardiol1993https://conductscience.org/library/papers/8421998PubMed
1620331602Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.Br J Pharmacol2010https://conductscience.org/library/papers/20331602PubMed
1738729987Klotho is highly expressed in the chief sites of regulated potassium secretion, and it is stimulated by potassium intake.Sci Rep2024https://conductscience.org/library/papers/38729987PubMed
1810471456The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.N Engl J Med1999https://conductscience.org/library/papers/10471456PubMed
1933153631Hyperkalemia and Acute Kidney Injury with Spironolactone Use Among Patients with Heart Failure.Mayo Clin Proc2020https://conductscience.org/library/papers/33153631PubMed
203208966Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist.Eur J Obstet Gynecol Reprod Biol1988https://conductscience.org/library/papers/3208966PubMed

See all 62 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42469710Non-steroidal mineralocorticoid receptor antagonists in non-diabetic kidney disease: a narrative review of mechanisms and clinical advances.BMC Nephrol2026https://conductscience.org/library/papers/42469710

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41301427

GET https://conductscience.org/api/papers/v1/41301427/references?page=2